Does inflammation link stress to poor COVID‐19 outcome?

Coronavirus disease 2019 (COVID‐19) continues to ravage communities across the world. Despite its primary effect on the respiratory system, the virus does not solely impact those with underlying lung conditions as initially predicted. Indeed, prognosis is worsened (often fatal) in patients with pre‐existing hyperinflammatory responses (e.g., hypertension, obesity and diabetes), yet the mechanisms by which this occurs are unknown. A number of psychological conditions are associated with inflammation, suggesting that these may also be significant risk factors for negative outcomes of COVID‐19. In this review, we evaluate preclinical and clinical literature suggesting that chronic stress‐induced hyperinflammation interacts synergistically with COVID‐19‐related inflammation, contributing to a potentially fatal cytokine storm syndrome. In particular, we hypothesize that both chronic stress and COVID‐19‐related hyperinflammation are a product of glucocorticoid insufficiency. We discuss the devastating effects of SARS‐CoV‐2 on structural and functional aspects of the biological stress response and how these induce exaggerated inflammatory responses, particularly interleukin (IL)‐6 hypersecretion. We postulate that chronic stress should be considered a significant risk factor for adverse COVID‐19‐related health outcomes, given overlapping peripheral and central immune dysregulation in both conditions. We conclude by discussing how people with a history of chronic stress could mitigate their risk for COVID‐19 complications, identifying specific strategies that can be implemented during self‐isolation.